The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans.
Jaeseong OhSeungHwan LeeHoward LeeJoo-Youn ChoSeo Hyun YoonIn-Jin JangKyung-Sang YuKyoung Soo LimPublished in: PloS one (2017)
ClinicalTtrials.gov NCT01902342.
Keyphrases